A 52-year-old, first-time blood donor presented with panreactivity during routine antibody screening. Current serologic evaluation showed uniform 2+ reactivity by the gel-indirect antiglobulin test and the conventional tube low-ionic-strength saline–indirect antiglobulin test. The molecular analyses revealed a homozygous 17–base pair deletion spanning nucleotides 64–80 in exon 3 of SMIM1 ( VEL*01N.01/VEL*01N.01 ), confirming the Vel-null phenotype. The antibody was identified as anti-Vel IgG3, reacting in tube testing, exclusively in the anti-human globulin phase. We present the first case of a Vel-null alloimmunized donor identified in Uruguay and describe the serologic, molecular, and functional characteristics of the associated antibody.
No takes yet. Share an insight, caveat, or question.
Tucuna et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: